The Breast
Volume 19, Issue 2 , Pages 92-96, April 2010

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy☆☆

  • Stephanie L. Hines

      Affiliations

    • Mayo Clinic Florida, Jacksonville, FL 32224, USA
    • Corresponding Author InformationCorresponding author at: Mayo Clinic Florida, Breast Center, 4500 San Pablo Road, Jacksonville, FL 32224, USA. Tel.: +1 904 953 0707; fax: +1 904 953 1412.
  • ,
  • Jeff A. Sloan

      Affiliations

    • Mayo Clinic Rochester, Rochester, MN 55905, USA
  • ,
  • Pamela J. Atherton

      Affiliations

    • Mayo Clinic Rochester, Rochester, MN 55905, USA
  • ,
  • Edith A. Perez

      Affiliations

    • Mayo Clinic Florida, Jacksonville, FL 32224, USA
  • ,
  • Shaker R. Dakhil

      Affiliations

    • Wichita Community Clinical Oncology, Wichita, KS 67214-3882, USA
  • ,
  • David B. Johnson

      Affiliations

    • Wichita Community Clinical Oncology, Wichita, KS 67214-3882, USA
  • ,
  • Pavan S. Reddy

      Affiliations

    • Wichita Community Clinical Oncology, Wichita, KS 67214-3882, USA
  • ,
  • Robert J. Dalton

      Affiliations

    • Immanuel-St. Joseph Hospital Mayo Health System, Mankato, MN 56002, USA
  • ,
  • Bassam I. Mattar

      Affiliations

    • Wichita Community Clinical Oncology, Wichita, KS 67214-3882, USA
  • ,
  • Charles L. Loprinzi

      Affiliations

    • Mayo Clinic Rochester, Rochester, MN 55905, USA

Received 19 June 2009; received in revised form 30 November 2009; accepted 1 December 2009. published online 15 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was conducted as a trial of the Mayo Cancer Center Research Consortium in part by Public Health Service grants CA-35431, CA-35195, and CA-52352. The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institute of Health.

☆☆ Additional participating institutions include: Carle Cancer Center CCOP, Urbana, IL 61801 (Kendrith M. Rowland, Jr.); Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA 52403 (Martin Wiesenfeld).

PII: S0960-9776(09)00173-8

doi:10.1016/j.breast.2009.12.001

The Breast
Volume 19, Issue 2 , Pages 92-96, April 2010